Assessing Patient-Reported Outcomes and Pharmacist Interventions in Multiple Sclerosis within an Integrated Care Center
Background: Patient-reported outcomes (PROs) responses can be used to measure patients health status, functioning, quality of life, and...
Patient Reported Outcomes from Pharmacist-Led Multiple Sclerosis Assessments in a Specialty Pharmacy Setting
Background: Disease-modifying therapy (DMT) has demonstrated benefits for patients in reducing relapse rates, disability progression, and...
Continued Expansion of a Multiple Sclerosis Pharmacy Program
Background: Kaiser Permanente Washington (KPWA) launched a Multiple Sclerosis (MS) Pharmacy Program in June 2014 to support patients on...
Integrated Clinic-Based Pharmacist Impact on Time to Fingolimod Treatment Initiation
Background: Multiple Sclerosis (MS) has no cure and causes irreversible damage to the brain and spinal cord leading to physical and...